1977 Henry H. Janeway lecture: fundamental mechanisms in combined modality therapy of cancer.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001973:Bromodeoxyuridine / Q000627:therapeutic use; D004260:DNA Repair; D004273:DNA, Neoplasm; D003609:Dactinomycin / Q000627:therapeutic use; D004583:Electrons; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D006979:Hyperthermia, Induced; D000860:Hypoxia; D007065:Idoxuridine / Q000627:therapeutic use; D007167:Immunotherapy; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000628:therapy; D011837:Radiation-Protective Agents / Q000627:therapeutic use; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use; D011879:Radiotherapy Dosage; D014111:Tourniquets; D014464:Ultrasonic Therapy
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D011837:Radiation-Protective Agents; D011838:Radiation-Sensitizing Agents; D003609:Dactinomycin; D001973:Bromodeoxyuridine; D007065:Idoxuridine; D005472:Fluorouracil